Work

Phase I/II trial of 177 Lu-NYM032 for progressive metastatic castration-resistant prostate cancer.

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17040

Authors: Peng Fang, Waisi Eng, Haitian Fu, P. David Mozley, Si Yang, Huihui He, Chunjing Yu

Institution: Wuxi Fourth People's Hospital

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809288

FWCI:

Cites:

Cited by:

Related to: 10